SKYE — Skye Bioscience Share News
0.000.00%
Last trade - 00:00Skye Bioscience Inc reports results for the quarter ended June 30 - Earnings Summary
Skye Bioscience Inc expected to post a loss of 31 cents a share - Earnings Preview
Brief: Skye Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Skye Bioscience Inc reports results for the quarter ended March 31 - Earnings Summary
Skye Bioscience Inc expected to post a loss of 29 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Dow, Nike, Coty
U.S. STOCKS ON THE MOVE-Caterpillar, Netflix, Bank of America
Skye Bioscience soars after experimental weight-loss drug shows promise in mice
U.S. STOCKS ON THE MOVE-Rocket Lab, Boeing, Citigroup
Brief: Skye Bioscience Demonstrates Over 30% Weight Loss With Nimacimab And Tirzepatide Combination In Preclinical Model
Skye Bioscience rises after experimental weight-loss drug shows promise in mice
Skye Bioscience Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Skye Bioscience Reports Fourth Quarter And Full Year 2024 Financial Results And Provides Business Update
Skye Bioscience Inc expected to post a loss of 28 cents a share - Earnings Preview
Brief: Skye Bioscience Surpasses 50% Patient Enrollment In Phase 2 Obesity Study Of Differentiated CB1 Inhibitor
Skye Bioscience Inc reports results for the quarter ended in September 30 - Earnings Summary
Skye Bioscience Inc expected to post a loss of 25 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-NetEase, Wolfspeed, B. Riley
U.S. STOCKS ON THE MOVE-Evogene, Stryker, Opera